Sequential Intravesical Gemcitabine and Docetaxel is an Alternative to Bacillus Calmette-Guérin for the Treatment of Intermediate-risk Non–muscle-invasive Bladder Cancer
Title:
Sequential Intravesical Gemcitabine and Docetaxel is an Alternative to Bacillus Calmette-Guérin for the Treatment of Intermediate-risk Non–muscle-invasive Bladder Cancer
Author:
Tan, Wei Shen McElree, Ian M. Davaro, Facundo Steinberg, Ryan L. Bree, Kelly Navai, Neema Dinney, Colin P. O'Donnell, Michael A. Li, Roger Kamat, Ashish M. Packiam, Vignesh T.